GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » Buyback Yield %

No.25 Central Pharmaceutical JSC (HSTC:UPH) Buyback Yield % : 0.00 (As of Apr. 15, 2025)


View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

No.25 Central Pharmaceutical JSC's current buyback yield was 0.00%.

No.25 Central Pharmaceutical JSC Buyback Yield % Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC Buyback Yield % Chart

No.25 Central Pharmaceutical JSC Annual Data
Trend
Buyback Yield %

No.25 Central Pharmaceutical JSC Semi-Annual Data
Buyback Yield %

Competitive Comparison of No.25 Central Pharmaceutical JSC's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, No.25 Central Pharmaceutical JSC's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

No.25 Central Pharmaceutical JSC's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, No.25 Central Pharmaceutical JSC's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where No.25 Central Pharmaceutical JSC's Buyback Yield % falls into.


;
;

No.25 Central Pharmaceutical JSC Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

No.25 Central Pharmaceutical JSC's Buyback Yield for the fiscal year that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- ( + ) /
=N/A%

No.25 Central Pharmaceutical JSC's annualized Buyback Yield for the quarter that ended in . 20 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- ( + ) /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

No.25 Central Pharmaceutical JSC Buyback Yield % Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

No.25 Central Pharmaceutical JSC Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » Buyback Yield %
Comparable Companies
Traded in Other Exchanges
N/A
Address
448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM
Website
https://uphace.vn
No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines